IFNA1 and synovial sarcoma: While rs7582694 risk variant has been associated with increased expression of several IFN-inducible genes in SS patients [79], PBMC derived from lupus patients harboring the risk variant of rs7574865 demonstrated increased sensitivity to IFNα effects [78].